Dr. John F. Reinus

Hatef Massoumi is a Transplant Surgeon in Bronx, New York. Dr. Massoumi is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hepatitis. His top areas of expertise are Hepatitis, Visceromegaly, Enlarged Liver, Thrombectomy, and Liver Transplant.

Kristina R. Chacko, MD, is an Associate Professor of Medicine at the Albert Einstein College of Medicine in Bronx, NY.  She joined the Einstein-Montefiore Liver Center in 2013 after completing a fellowship in Transplant Hepatology at Mount Sinai School of Medicine in New York, NY.  She received her bachelor of arts in philosophy at Boston College and attended medical school at Baylor College of Medicine in Houston, TX.  She completed her internal medicine residency at Emory University in Atlanta, GA, and gastroenterology fellowship at New York University.  Her clinical and research interests include the diagnosis and management of alcoholic hepatitis, non-alcoholic fatty liver disease, autoimmune liver diseases, and liver transplantation.  As the program director of the ACGME-accredited transplant hepatology fellowship at Montefiore Medical Center, she is directly involved in the development and execution of the hepatology curriculum for gastroenterology and hepatology fellows. Dr. Chacko is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hepatitis. Her top areas of expertise are Hepatitis, Hepatitis A, Visceromegaly, Hepatitis C, and Liver Transplant.

Dr. Sanjaya K. Satapathy is the medical director of the Center for Liver Disease and Transplantation at the Northwell Transplant Institute, program director of Northwell's Transplant Hepatology Fellowship, and professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.His path to medicine began in India, where he was inspired by his father an engineer with a passion for homeopathy to pursue a career in healthcare. He earned his medical degree from Veer Surendra Sai Medical College, followed by fellowship training in gastroenterology and hepatology in the early 2000s. During that time, he witnessed the profound need for liver transplantation in India, where access remained scarce.While presenting his research at a conference in the United States, Dr. Satapathy was drawn to the opportunities and possibilities for advancing transplantation in America. He decided to continue his career in the United States, completing additional residency and fellowship training before serving as a transplant hepatologist in Memphis. In 2019, he was recruited to Northwell.It was a dream to begin from zero and build a transplant program that could be a model not just for the area or the state, but for the country, says Dr. Satapathy. Within only a few years, we've been able to achieve that goal, because Northwell has all the elements and resources to be one of the best programs in the nation. The expertise we have is unparalleled, with a collaborative team that encompasses all levels of care.The program was founded just in time for a huge surge in demand for liver transplants in the area, he adds. Liver disease and other liver issues are on the rise, making the need for an extensive program crucial for those in the New York region. Part of the program's strength is innovation. For example, Northwell is utilizing an approach that allows donated organs to be safely preserved for a longer period of time, which means needed organs can travel longer distances even from as far away as Hawaii. Northwell is also running several clinical trials on transplant medications and operates a robust transplant hepatology fellowship program to train the next generation of doctors a program Dr. Satapathy launched.I'm passionate about this work, and particularly about my patients, he says. I see every patient as my family, and my focus is on what I can do next to help them. Dr. Satapathy is rated as an Elite provider by MediFind in the treatment of Autoimmune Hepatitis. His top areas of expertise are Spontaneous Bacterial Peritonitis, Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Liver Transplant, and Endoscopy.